Biotech Co. Faces Investor Suit Over 'Misleading' Merger Info
AmpliPhi and its directors are improperly withholding key information from investors ahead of a vote to approve its deal to be bought by fellow biotechnology company C3J Therapeutics, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article